Publications | PubMed=6806672; DOI=10.1038/298474a0 Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 298:474-476(1982) PubMed=6825067; DOI=10.1016/0165-4608(83)90138-3 Bernheim A., Berger R., Lenoir G.M. Cytogenetic studies on Burkitt's lymphoma cell lines. Cancer Genet. Cytogenet. 8:223-229(1983) PubMed=6592381; DOI=10.1093/jnci/73.4.841 Favrot M.-C., Philip I., Philip T., Portoukalian J., Dore J.-F., Lenoir G.M. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin. J. Natl. Cancer Inst. 73:841-847(1984) PubMed=3004968; DOI=10.1002/j.1460-2075.1985.tb04140.x; PMCID=PMC554723 Eick D., Piechaczyk M., Henglein B., Blanchard J.-M., Traub B., Kofler E., Wiest S., Lenoir G.M., Bornkamm G.-W. Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J. 4:3717-3725(1985) PubMed=3905596 Favrot M.-C., Philip I., Philip T., Cabrillat H., Pinatel C., Dore J.-F., Lenoir G.M. Immunophenotypic classification of 28 Burkitt cell lines with monoclonal antibodies and reagent selection for bone-marrow purging. IARC Sci. Publ. 60:447-452(1985) PubMed=3934070 Lenoir G.M., Vuillaume M., Bonnardel C. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci. Publ. 60:309-318(1985) PubMed=2825176; DOI=10.1073/pnas.84.22.8060; PMCID=PMC299477 Calender A., Billaud M., Aubry J.-P., Banchereau J., Vuillaume M., Lenoir G.M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 84:8060-8064(1987) PubMed=3027441; DOI=10.1093/jnci/78.2.235 Cohen J.H.M., Revillard J.-P., Magaud J.-P., Lenoir G.M., Vuillaume M., Manel A.-M., Vincent C., Bryon P.-A. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. J. Natl. Cancer Inst. 78:235-242(1987) PubMed=3035497; DOI=10.1093/nar/15.11.4553; PMCID=PMC340879 Szajnert M.-F., Saule S., Bornkamm G.-W., Wajcman H., Lenoir G.M., Kaplan J.-C. Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation. Nucleic Acids Res. 15:4553-4565(1987) PubMed=3026973; DOI=10.1002/ijc.2910390215 Ehlin-Henriksson B., Manneborg-Sandlund A., Klein G. Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. Int. J. Cancer 39:211-218(1987) PubMed=1915267; DOI=10.1002/j.1460-2075.1991.tb07837.x; PMCID=PMC452998 Farrell P.J., Allan G.J., Shanahan F., Vousden K.H., Crook T. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 10:2879-2887(1991) PubMed=2052620; DOI=10.1073/pnas.88.12.5413; PMCID=PMC51883 Gaidano G., Ballerini P., Gong J.Z., Inghirami G., Neri A., Newcomb E.W., Magrath I.T., Knowles D.M., Dalla-Favera R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 88:5413-5417(1991) PubMed=1356511; DOI=10.1182/blood.V80.7.1781.1781 Gaidano G., Hauptschein R.S., Parsa N.Z., Offit K., Rao P.H., Lenoir G.M., Knowles D.M., Chaganti R.S.K., Dalla-Favera R. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80:1781-1787(1992) PubMed=8896424; DOI=10.1182/blood.V88.9.3562.bloodjournal8893562 Chapman C.J., Zhou J.X., Gregory C.D., Rickinson A.B., Stevenson F.K. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 88:3562-3568(1996) PubMed=9473234; DOI=10.1182/blood.V91.5.1680 Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91:1680-1687(1998) PubMed=11793449; DOI=10.1002/gcc.10022 Sobol H., Benziane A., Kerangueven F., Yin L., Noguchi T., Pauly S., Eisinger F., Longy M., Romeo G., Lenoir G.M., Birnbaum D. Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines. Genes Chromosomes Cancer 33:217-224(2002) PubMed=22885699; DOI=10.1038/nature11378; PMCID=PMC3609867 Schmitz R., Young R.M., Ceribelli M., Jhavar S., Xiao W.-M., Zhang M.-L., Wright G., Shaffer A.L. 3rd, Hodson D.J., Buras E., Liu X.-L., Powell J.I., Yang Y.-D., Xu W.-H., Zhao H., Kohlhammer H., Rosenwald A., Kluin P.M., Muller-Hermelink H.-K., Ott G., Gascoyne R.D., Connors J.M., Rimsza L.M., Campo E., Jaffe E.S., Delabie J., Smeland E.B., Ogwang M.D., Reynolds S.J., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.-C., Pittaluga S., Wilson W., Waldmann T.A., Rowe M., Mbulaiteye S.M., Rickinson A.B., Staudt L.M. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116-120(2012) PubMed=24590883; DOI=10.1002/gcc.22161 Murga Penas E.-M., Schilling G., Behrmann P., Klokow M., Vettorazzi E., Bokemeyer C., Dierlamm J. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples. Genes Chromosomes Cancer 53:497-515(2014) PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981 Boegel S., Lower M., Bukur T., Sahin U., Castle J.C. A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. OncoImmunology 3:e954893.1-e954893.12(2014) |